Actively Recruiting

Phase 3
Age: 8Years - 18Years
All Genders
NCT07553182

OLE Study With Filgotinib in JIA

Led by Alfasigma S.p.A. · Updated on 2026-04-27

80

Participants Needed

4

Research Sites

84 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This OLE study is designed to evaluate long-term safety, tolerability, and efficacy of filgotinib in patients with polyarticular or systemic juvenile idiopathic arthritis (pJIA-sJIA) who have completed the treatment period/prolonged treatment period of the parent studies and demonstrated clinical benefit defined as control of disease activity through improvement in signs and symptoms as per Investigator judgement.

CONDITIONS

Official Title

OLE Study With Filgotinib in JIA

Who Can Participate

Age: 8Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Child must have completed treatment with filgotinib in at least one parent study and shown clinical benefit
  • Child and/or parent or legal guardian must be able and willing to follow the study protocol and sign informed consent and assent forms as required
  • Female or male child aged 8 to less than 18 years at the time of consent
  • Female child of childbearing potential who is sexually active must agree to use contraception as described in the protocol
Not Eligible

You will not qualify if you...

  • Any condition developed during the parent study that would make continuing treatment unsafe
  • Pregnancy
  • Active infection considered clinically significant by the investigator
  • Known hypersensitivity to any components of the study treatment
  • Any condition or circumstance, including abnormal lab results, that may prevent the child from completing the study or following study procedures as judged by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Bicetre Hospital

Le Kremlin-Bicêtre, France, 94270

Not Yet Recruiting

2

Hamburger Zentrum für Kinder- und Jugendrheumatologie

Hamburg, Germany, 22081

Actively Recruiting

3

Asklepios Klinik Sankt Augustin GmbH

Sankt Augustin, Germany, 53757

Not Yet Recruiting

4

Great Ormond Street Hospital for Children

London, United Kingdom, WC1N 3JH

Not Yet Recruiting

Loading map...

Research Team

C

Catherine Vincent

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

OLE Study With Filgotinib in JIA | DecenTrialz